Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations
- Authors
- Type
- Published Article
- Journal
- Journal of the Pediatric Infectious Diseases Society
- Publisher
- Oxford University Press
- Volume
- 2
- Issue
- 3
- Pages
- 205–214
- Identifiers
- DOI: 10.1093/jpids/pit007
- Source
- Kaiser Perinatal
- License
- White
Abstract
Immunoprophylaxis is the only pharmaceutical intervention for mitigating respiratory syncytial virus (RSV) infection. Patient level data on adherence to American Academy of Pediatrics (AAP) immunoprophylaxis recommendations are limited. This study characterizes adherence to AAP guidelines in privately insured and Medicaid populations
